Wed, Jul 23, 2014, 7:06 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Merrimack Pharmaceuticals, Inc. (MACK) Message Board

  • iyxing515 iyxing515 Nov 27, 2013 6:23 AM Flag

    Did anyone listen to the CC yesterday?

    I didn't get to listen to it, so I have been reading the news only. If I didn't read it wrong, MM121 has been validated, which is exiting.

    Why do you guys think about the result? NO BASHING, if you want to bash, please go to the next door, this is for DISCUSSION ONLY.

    I will read more into it once the official study is published in medical journal, but I guess that can take a while.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I am very positive about the outcome. It will get approval to go into phase 3. Phase 3 will be paid by the money (2 million dollars now and in total 15million dollars) by a partnership for nanotech with Actavis. So when their current phase 3 product brings out good results in Q2 2014 and will be approved by the FDA, the commercialization will bring net profit and will not have to be used to pay for their other clinical studies.

      Yesterdays' news was extermely important. Analyst will be recalculation their projections in the positive way. 7dollar/share will be too conservative as a year target.

      Sentiment: Strong Buy

 
MACK
6.00+0.11(+1.87%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.